Strategies to identify disease genes.
The correlation between genes and disease began in earnest in the early 1900s with the identification of Mendelian-like inheritance of "inborn errors of metabolism." Since then, the ever-broadening field of genetics has been established as one of the most important and groundbreaking branches of science and medicine to date. With the announcement of a "working draft" sequence of the human genome in 2001, the vast array of both genomic and expressed sequence information available in the public databases alone has meant that the concept of hunting for genes is evolving. Nowadays, researchers can substitute many labor-intensive hours in the lab for less time searching on the World Wide Web. Specialization within genetics has been continuously providing subsets of the genre such as genomics, pharmacogenetics, chemogenomics, gene therapy, proteomics and functional genomics, all of which are based on the fundamental starting block, the gene. This review aims to summarize both traditional and current strategies for identifying susceptibility and monogenetic disease genes and describes how these strategies have evolved in tune with the ever-expanding wealth of information now available at our fingertips.
Ashton
Gabrielle H S
GH
Department of Cell and Molecular Pathology, St. John's Institute of Dermatology, The Guy's, King's College and St. Thomas' Hospitals' Medical School, St. Thomas' Hospital, London, UK.
McGrath
John A
JA
South
Andrew P
AP
D000818:Animals; D002874:Chromosome Mapping; D030342:Genetic Diseases, Inborn / Q000235:genetics*; D008040:Genetic Linkage; D005826:Genetics, Medical; D006720:Homozygote; D006801:Humans; D010597:Pharmacogenetics